A leader in automated microbial contamination detection for pharmaceutical manufacturing, Rapid Micro Biosystems accelerates the detection of microbial contamination in the manufacture of pharmaceuticals, biologics, medical devices, and personal care products. Designed to replace slow, error-prone, manual processes, the companys Growth Direct Platformthe first and only growth-based platform to fully automate traditional microbial testingdetects contamination more quickly, delivering compelling economic benefits while improving quality control processes - allowing manufacturers to accelerate timelines, maximize capacity, and reduce operational risk and downtime, all while maintaining the highest standards of data integrity. Headquartered in Lowell, MA, Rapid Micro Biosystems also has faciliites in Germany and the Netherlands.
